Drug shortages create significant challenges for patients and health care providers. Pharmacists play important roles in managing medication therapy during drug shortages. The management of drug shortages by the community pharmacist is an expanding role. Adverse drug reactions and delayed treatments are highlighted in the literature as some of the consequences of outpatient drug shortages; it is likely these harms are underreported. This commentary reviews examples and opportunities for the management of outpatient drug shortages.
While the majority of shortages are generic, injectable agents that mostly affect the inpatient population, outpatient drug shortages also create significant challenges for health care professionals and patients. 1 These shortages negatively affect the direct pharmaceutical care provided by pharmacists and other health care providers and require tremendous human resources. 2 The roles of community pharmacists are expanding in chronic disease management and prevention to ensure effective, safe, and efficient use of medications by establishing ongoing initiatives to improve the quality of prescription drug therapy. 3 The role of both outpatient and community pharmacists now includes the management of drug shortages. The American Society of Health-System Pharmacists (ASHP) Drug Shortage Guidelines mainly focus on management of inpatient drug product shortages, and more information is needed regarding the management of outpatient drug product shortages. 2
Examples of Outpatient Drug Shortages
Various reasons for drug shortages exist, including the following issues: supply/demand, raw and bulk material, manufacturing, wholesale and distribution, market structure, and regulatory. 2 In addition, a shortage can occur at any stage of the pharmaceutical distribution chain. Table 1 lists select examples of outpatient drug shortages from the United States that have been collected by the University of Utah Drug Information Service. A few of these examples are highlighted below.
In November 2012, a manufacturer reported a shortage of isoniazid 300 mg tablets due to difficulty in obtaining the active ingredient. In December 2012, the Centers for Disease Control and Prevention encouraged pharmacies to dispense isoniazid 100 mg tablets until the shortage of isoniazid 300 mg was resolved. 4 In January 2014, the Food and Drug Administration (FDA) announced a national shortage of oseltamivir oral suspension. During that time only oseltamivir 75 mg capsules were available. 5 Since pediatric patients may not be able to swallow capsules, the FDA reminded health care professionals to use approved compounding instructions available on the FDA website as well as on the product label to compound oral suspension from the 75 mg capsules. 5
Impact of Outpatient Drug Shortages
There have been several surveys of outpatient pharmacists regarding drug shortages. A prospective study was conducted in Ireland from October 2012 to February 2013, attempting to discover the numbers of drug shortages and the durations of those shortages. The authors found that 65/1232 (5.3%) of the dispensed drugs were unavailable with a median 13 days of unavailability. After the authors spoke with the manufacturers and wholesalers, they discovered that reasons for the shortages could be categorized into the following: parallel (unauthorized) exportation (11/65, 17%), manufacturing/licensing issues (16/65, 25%), excess demand (10/65, 15%), and unknown causes (28/65, 43%). 6 In Finland, pharmacists from 195 randomly selected pharmacies were asked to fill out forms regarding medicines on shortage. 7 One hundred twenty-nine pharmacies (66%) responded, and 79.8% of those pharmacists reported experiencing daily shortages or almost daily shortages. The reason for the shortage was provided to 11.2% of those pharmacists. Most of the medications on shortage were commonly used medications needed for the nervous system (30.8%) and cardiovascular indications (17.5%). Approximately half of the cases had available alternative medications. Of all the medicines on shortage, 44.8% were less expensive than most medications, and 39.3% were the least expensive alternative. The study highlighted the increased workload for the pharmacists when experiencing a drug shortage, which ultimately leads to patient dissatisfaction. 7 There have also been several cases illustrating the unintended consequences outpatient drug shortages have on patients. In 2012, the Canadian supply of trimethoprimsulfamethoxazole (TMP-SMX) was jeopardized when 2 major manufacturers experienced backorders of the drug. 8 A case report detailed a highly immune-suppressed 54-year-old patient who developed a brain abscess from Nocardia after being switched to dapsone from TMP-SMX. Unfortunately, most alternative agents have little or no activity against Nocardia species infections. 8 In France, a shortage in 2012 led to the substitution of 100 mg phenytoin with 100 mg phenytoin sodium. 9 The results of the substitution were detailed in a case series and included the following: hospitalizations, increases in epileptic attacks, memory issues, thymic disorders, and one death. 9 A case was reported in which a 75-year-old woman self-discontinued ticlopidine for her dual antiplatelet therapy because of its lack of availability from the pharmacy. 10 Fortunately, the alternative therapy was well tolerated by the patient. 10
Role of the Community Pharmacist in the Management of Drug Shortages
As the majority of the published evidence is linked to inpatient drug shortages, there is considerable need for appropriate management strategies for outpatient drug shortages. For patients, pharmacists are usually the first resource to help with drug shortage issues. In general, the FDA Drug Shortages or ASHP Drug Shortage websites are the starting point to determine the extent and nature of a drug shortage. When a drug is backordered or discontinued, the pharmacy team should contact the patient to explain the situation and advise of any delays in medication access. If an alternative manufacturer is to be used, the patient should be counseled that the medication will have a different appearance. Other courses of action include proposing a list of appropriate alternatives to the physician for substitution, contacting other community or mail order pharmacies (if the patient is eligible for mail order service through their insurance) to check for inventory, and contacting the pharmacy wholesaler for updates. The pharmacy team can also help reduce out-of-pocket costs by notifying third party payers and advising them of the shortage and alternative products that may need to be added to their formulary.
Potential Role of Pharmacy Benefit Managers in the Management of Drug Shortages
Pharmacy Benefit Managers (PBMs) also play a role in managing drug shortages. 11 They efficiently distribute medications throughout all 50 states via mail order and specialty dispensing operations; capabilities that can be used during life-threatening shortages to properly manage remaining inventory. PBMs may play a role in preventing shortages from worsening by (1) providing advance notice to suppliers if the PBM intends to prefer one product over another, (2) preventing active shortages from intensifying by allowing patients to access alternatives or nonpreferred agents at the patient's usual co-payment rate, and (3) giving access to those with the highest priority by using "prior authorization" programs. 11 PBMs could possibly merge their resources with larger health care organizations such as public and private integrated health care systems, national health insurance carriers and managed care organizations, national pharmacy chains, prescription drug wholesalers, and comprehensive care networks to extend these capabilities and provide access to potentially lifesaving therapies. 11 The appropriate management of drug shortages is imperative. As such, the role of the outpatient and community pharmacist regarding drug shortages will continue to evolve. Many cases have been reported highlighting the harms that outpatient drug shortages have caused, and it is likely that these harms have been underreported. All clinicians should continue to advocate for a global solution for the drug shortages issue and continue to research the consequences of these shortages. For pharmacists and health care professionals, improving communication among all stakeholders regarding medications will be needed as drug shortage issues continue to occur.
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